|
National Stock Number(NSN): 6505-00-092-3060 (6505000923060, 000923060)
| NIIN: |
00-092-3060 |
Item Name: |
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION |
INC: |
30937
|
| FSC: |
6505
|
Assignment Date: |
Nov-29-1972 |
CRIT: |
N |
IIG: |
30937 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
7 |
Cancellation Date: |
Sep-01-1997 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-156-1816 |
Item Name: |
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION |
| FSC: |
6505 |
Replacement Date: |
Sep-01-1997 |
|
INC: |
30937 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
E.E.S. |
59362
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
H |
5 |
1 |
6 |
54 |
4 |
D |
|
|
|
|
|
NDC00074-6369-05 |
59362
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
H |
3 |
2 |
6 |
54 |
1 |
D |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| VA |
JVS |
Y |
|
M |
U |
0 |
V |
$0.00 |
BT |
|
------- |
Sep-01-1992 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| VA |
K |
U/I CONTAINS 5ML |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
200.000 MILLIGRAMS ERYTHROMYCIN ETHYLSUCCINATE ACTIVE INGREDIENT |
| ALJH |
FLAVOR |
FRUIT |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
GRANULAR POWDER SUFFICIENT TO CONTAIN 200 MILLIGRAMS OF ERYTHROMYCIN ETHYLSUCCINATE |
| CSGS |
ADMINISTRATION |
ORAL |
| FEAT |
SPECIAL FEATURES |
TO BE RECONSTITUTED TO 5 ML |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G652 |
|
Apr-01-1991 |
0 |
0 |
|
|
54|65 |
54|65 |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|